Skip to main content

IORT for Head and Neck Cancer

  • Chapter

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Current standard treatment for locally advanced but resectable (stages III and IV and selected stage II) head and neck cancer includes surgery combined with preoperative or postoperative radiation therapy or radiation therapy alone or combined with a neck dissection with surgery reserved for salvage. Chemotherapy may be added. However, other than a neoadjuvant role for organ preservation in advanced larynx or pyriform sinus cancer and a concomitant and maintenance role in advanced nasopharyngeal cancer, the role for chemotherapy remains to be defined (1–3). Despite advances made in recent years with combined modality therapy, local and regional recurrence rates remain unacceptably high (20–60%), and 5-year survival rates remain disappointingly low (30–60%).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. The Department of Veterans Affairs Laryngeal Cancer Study Group, Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer, N. Engl. J. Med., 324 (1991) 1675–1690.

    Google Scholar 

  2. Lefebrre JL, Chevalier D, Luboinski B, et al. Larynx preservation in piriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III Trial, J. Natl. Cancer Inst., 88 (1996) 890–899.

    Article  Google Scholar 

  3. Al-Sarraf M, LeBlanc M, Giri PGS, et al. Improved overall survival with chemoradiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal Cancer (NPC). Preliminary results of Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Randomized Study, Fourth International Conference on Head and Neck Cancer, Toronto, 1996, p. 118.

    Google Scholar 

  4. Kramer S, Gelber RD, Snow JB, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73–03 of the Radiation Therapy Oncology Group, Head Neck Surg., 10 (1987) 19–30.

    Article  PubMed  CAS  Google Scholar 

  5. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial, Int. J. Radiat. Oncol. Biol. Phys., 26 (1993) 3–11.

    Article  PubMed  CAS  Google Scholar 

  6. Tupchong L, Scott CB, Blitzer PH, et al. Randomized Study of Preoperative Versus Postoperative Radiation Therapy in Advanced Head and Neck Carcinoma: Long-Term Follow-Up of RTOG Study 73–03, Int. J. Radiat. Oncol. Biol. Phys., 20 (1991) 21–28.

    Article  PubMed  CAS  Google Scholar 

  7. Ang KK, Trotti A, Garden AS, et al. Importance of Overall Time Factor in Postoperative Radiation Therapy, Proceedings Fourth International Conference on Head and Neck Cancer, Toronto, 1996, pp. 231–235.

    Google Scholar 

  8. Laramore GE, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034, Int. J. Radiat. Oncol. Biol. Phys., 23 (1992) 705–713.

    Article  PubMed  CAS  Google Scholar 

  9. Adjuvant Chemotherapy for Advanced Head and Neck Squamous Carcinoma, Final Report of the Head and Neck Contracts Program. Cancer, 60 (1987) 301–311.

    Article  Google Scholar 

  10. Schuller DE, Metch B, and Stein DW. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group, Laryngoscope, 98 (1988) 1205–1211.

    Article  PubMed  CAS  Google Scholar 

  11. Holoye PY, Grossman TW, Toohill RJ, et al. Randomized study of adjuvant chemotherapy for head and neck cancer, Otolarngol. Head Neck Surg., 93 (1985) 712–717.

    CAS  Google Scholar 

  12. Olsen KD, Caruso M, Foote RL, et al. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement, Arch. Otolaryngol. Head Neck Surg., 120 (1994) 1370–1374.

    Article  PubMed  CAS  Google Scholar 

  13. Chen TY, Emrich LJ, and Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 13 (1987) 833–837.

    Article  PubMed  CAS  Google Scholar 

  14. Scholl P, Byers RM, Batsakis JG, et al. Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue. Prognostic and therapeutic implications, Ann. J. Surg., 152 (1986) 354–360.

    Article  CAS  Google Scholar 

  15. Looser KG, Shah JP, and Strong EW. The significance of “positive” margins in surgically resected epidermoid carcinomas, Head Neck Surg., 1 (1978) 107–111.

    Article  PubMed  CAS  Google Scholar 

  16. Zbaeren P and Lehmann W. Frequency and sites of distant metastases in head and neck squamous cell carcinoma, Arch. Otolaryngol. Head Neck Surg., 113 (1987) 762–764.

    Article  Google Scholar 

  17. Huang D, Johnson CR, Schmidt-Ullrich RK, et al. Incompletely resected advanced squamous cell carcinoma of the head and neck: the effectiveness of adjuvant vs salvage radiotherapy, Radiother. Oncol., 24 (1992) 87–93.

    Article  PubMed  CAS  Google Scholar 

  18. Byers RM, Bland KI, Borlase B, et al. The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck, Ann. J. Surg., 136 (1978) 525–528.

    Article  CAS  Google Scholar 

  19. Laramore GE, Scott CB, Schuller DE, et al. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the Intergroup Study 0034 and the Radiation Therapy Oncology Group Head and Neck Database, Int. J. Radiat. Oncol. Biol. Phys., 27 (1993) 1011–1016.

    Article  PubMed  CAS  Google Scholar 

  20. Zelefsky MJ, Harrison LB, Fass DE, et al. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins, Int. J. Radiat. Oncol. Biol. Phys., 25 (1992) 17–21.

    Article  Google Scholar 

  21. Ahmad K, Cordoba RB, and Fayos JV. Squamous cell carcinoma of the maxillary sinus, Arch. Otolaryngol., 107 (1981) 48–51.

    Article  PubMed  CAS  Google Scholar 

  22. Beale FA and Garrett PG. Cancer of the paranasal sinuses with particular reference to maxillary sinus cancer, J. Otolaryngol., 12 (1983) 377–382.

    PubMed  CAS  Google Scholar 

  23. Kondo M, Ogawa K, Inuyama Y, et al. Prognostic factors influencing relapse of squamous cell carcinoma of the maxillary sinus, Cancer, 55 (1985) 190–196.

    Article  PubMed  CAS  Google Scholar 

  24. Korzeniowski S, Reinfuss M, and Skolyszewski J. The evaluation of radiotherapy after incomplete surgery in patients with carcinoma of the maxillary sinus, Int. J. Radiat. Oncol. Biol. Phys., 11 (1985) 505–509.

    Article  PubMed  CAS  Google Scholar 

  25. Tsujii H, Kamada T, Arimoto T, et al. The role of radiotherapy in the management of maxillary sinus carcinoma, Cancer, 57 (1986) 2261–2266.

    Article  PubMed  CAS  Google Scholar 

  26. Gadeberg CC, Hjelm-Hausen M, Sogaard H, et al. Malignant tumors of the paranasal sinuses and nasal cavity. A series of 180 patients, Acta Radiol. Oncol., 23 (1984) 181–187.

    Article  PubMed  CAS  Google Scholar 

  27. Rush SE and Bagshaw MA. Carcinoma of the paranasal sinuses, Cancer, 50 (1982) 154–158.

    Article  Google Scholar 

  28. Hordijk GJ and Brons EN. Carcinomas of the maxillary sinus: a retrospective study, Clin. Otolaryngol., 10 (1985) 285–288.

    Article  PubMed  CAS  Google Scholar 

  29. Hu YH, Tu GY, Qi YQ, et al. Comparison of pre-and postoperative radiation in the combined treatment of carcinoma of maxillary sinus, Int. J. Radiat. Oncol. Biol. Phys., 8 (1982) 1045–1049.

    Article  PubMed  CAS  Google Scholar 

  30. Knegt PP, de Jong PC, van Andel JG, et al. Carcinoma of the paranasal sinuses. Results of a prospective pilot study, Cancer, 56 (1985) 57–62.

    Article  PubMed  CAS  Google Scholar 

  31. Lindeman P, Eklund V, and Petruson B. Survival after surgical treatment in maxillary neoplasms of epithelial origin, J. Laryngol. Otol., 101 (1987) 564–568.

    Article  PubMed  CAS  Google Scholar 

  32. Sakai S, Hohki A, Fuchihata H, et al. Multidisciplinary treatment of maxillary sinus carcinoma, Cancer, 52 (1983) 1360–1364.

    Article  PubMed  CAS  Google Scholar 

  33. Schlappack OK, Dobrowsky W, Schratter M, et al. Radiotherapy of carcinoma of the paranasal sinuses, Strahlenter. Oncol., 162 (1986) 291–299.

    CAS  Google Scholar 

  34. St. Pierre S and Baker SR. Squamous cell carcinoma of the maxillary sinus: analysis of 66 cases, Head Neck Surg., 5 (1983) 508–513.

    Article  Google Scholar 

  35. Roa WH, Hazuka MB, Sandler HM, et al. Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinuses, Int. J. Radiat. Oncol. Biol. Phys., 28 (1994) 857–865.

    Article  PubMed  CAS  Google Scholar 

  36. Hong WK, Bromer RH, Amato DA, et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality treatment, Cancer,45 (1985)1242–1249.

    Google Scholar 

  37. Deutsch M, Leen R, Parsons JA, et al. Radiotherapy for postoperative recurrent squamous cell carcinoma in head and neck, Arch. Otolaryngol., 98 (1973) 316–318.

    Article  PubMed  CAS  Google Scholar 

  38. Pearlman NW. Treatment outcome in recurrent head and neck cancer, Arch. Surg., 114 (1979) 39–42.

    Article  PubMed  CAS  Google Scholar 

  39. Emami B, Bignardi M, Devineni VR, et al. Reirradiation of recurrent head and neck cancers, Laryngoscope, 97 (1987) 85–88.

    Article  PubMed  CAS  Google Scholar 

  40. Langlois D, Eschwege F, Kramar A, et al. Reirradiation of head and neck cancers, Radiother. Oncol., 3 (1985) 27–33.

    Article  PubMed  CAS  Google Scholar 

  41. Pomp J, Levendag PC, and van Putten WLJ. Reirradiation of recurrent tumors in the head and neck, Am. J. Clin. Oncol., 11 (1988) 543–549.

    Article  PubMed  CAS  Google Scholar 

  42. Skolyszewski J, Korzeniowski, S, and Reinfuss M. The reirradiation of recurrences of head and neck cancer, Br. J. Radiol., 53 (1980) 462–465.

    Article  PubMed  CAS  Google Scholar 

  43. Stevens KR, Britsch A, and Moss WT. High-dose reirradiation of head and neck cancer with curative intent, Int. J. Radiat. Oncol. Biol. Phys., 29 (1994) 687–698.

    Article  PubMed  Google Scholar 

  44. Fu KK, Newman H, and Phillips TL. Treatment of locally recurrent carcinoma of the nasopharynx, Radiology, 117 (1975) 425–431.

    PubMed  CAS  Google Scholar 

  45. Nisar Syed AM, Feder BH, George FW, et al. Iridium-192 after loaded implant in the retreatment of head and neck cancer, Br. J. Radiol., 51 (1978) 814–820.

    Article  Google Scholar 

  46. Thompson RW, Scottie Doggett RL, and Bagshaw MA. Ten year experience with linear accelerator irradiation of cancer of nasopharynx, Radiology, 97 (1970) 149–155.

    PubMed  CAS  Google Scholar 

  47. Vokes EE, Haraf DJ, Mick R, et al. Intensified concomitant chemoradiotherapy with and without filgrastim for poor prognosis head and neck cancer, J. Clin. Oncol., 12 (1994) 2351–2359.

    PubMed  CAS  Google Scholar 

  48. Hartsell WF, Thomas CR, Murthy AK, et al. Pilot study for the evaluation of simultaneous cisplatin/ 5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (ESTP-C385), Am. J. Clin. Oncol. (CCT), 17 (1994) 338–343.

    Article  CAS  Google Scholar 

  49. Weppelmann B, Wheeler RH, Peters GE, et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation, Int. J. Radiat. Oncol. Biol. Phys.,22 (1992) 10511056.

    Google Scholar 

  50. Spencer S, Wheeler R, Meredith R, et al. Simultaneous hydroxyurea, 5-fluorouracil, and high-dose BID irradiation in previously irradiated patients with recurrent squamous cell cancer of the head and neck, Third International Conference on Head and Neck Cancer, San Francisco, 1992.

    Google Scholar 

  51. Emami B and Marks JE. Retreatment of recurrent carcinoma of the head and neck by afterloading interstitial 192-Ir implant, Laryngoscope, 93 (1983) 1345–1347.

    PubMed  CAS  Google Scholar 

  52. Mazeron JJ, Langlois D, Glaubiger D, et al. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases, Int. J. Radiat. Oncol. Biol. Phys., 13 (1987) 957–962.

    Article  PubMed  CAS  Google Scholar 

  53. Puthawala AA and Syed AMN. Interstitial reirradiation for recurrent and/or persistent head and neck cancers, Int. J. Radial. Oncol. Biol. Phys., 13 (1987) 1113–1114.

    Article  CAS  Google Scholar 

  54. Vikram B and Mishra S Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins, Head Neck, 16 (1994) 155–157.

    Article  PubMed  CAS  Google Scholar 

  55. Fee WE Jr, Goffinet DR, Paryani S, et al. Intraoperative iodine-125 implants: their use in large tumors in the neck attached to the carotid artery, Arch. Otolaryngol. Head Neck Surg., 109 (1983) 727–730.

    Article  Google Scholar 

  56. Kumar PP, Good RR, Yonkers AJ, et al. High activity iodine-125 endocurie therapy for head and neck tumors, Laryngoscope, 99 (1989) 174–178.

    Article  PubMed  CAS  Google Scholar 

  57. Chen KY, Mohr RM, and Silverman CL. Interstitial iodine 125 in advanced recurrent squamous cell carcinoma of the head and neck with follow-up evaluation of carotid artery by ultrasound, Ann. Otol. Rhinol. Laryngol., 105 (1996) 955–961.

    PubMed  CAS  Google Scholar 

  58. Emami B, Marks JE, Perez CA, et al. Interstitial thermoradiotherapy in the treatment of recurrent/ residual malignant tumors, Am. J. Clin. Oncol., 7 (1984) 699–704.

    Article  PubMed  CAS  Google Scholar 

  59. Puthawala AA, Syed AMN, Sheiku KMA, et al. Interstitial hyperthermia for recurrent malignancies. Endocurie Therapy/Hypertherm. Oncol., 1 (1985) 125–131.

    Google Scholar 

  60. Tupchong L, Waterman FM, and McFarlane JD. Hyperthermia and radiation therapy for advanced regional disease due to recurrent head and neck carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 19 (1990) 1099.

    Google Scholar 

  61. Hong WK and Bromer R. Chemotherapy in head and neck cancer, N. Engl. J. Med., 308 (1983) 75–79.

    Article  PubMed  CAS  Google Scholar 

  62. Pryzant RM, Wendt CD, Delclos L, Peters LI, et al. Retreatment of nasopharyngeal carcinoma in 53 patients, Int. J. Radiat. Oncol. Biol. Phys., 22 (1992) 941–947.

    Article  PubMed  CAS  Google Scholar 

  63. Benchalal M, Bachaud JM, Francois P, et al. Hyperfractionation in the reirradiation of head and neck cancer, Results of a pilot study, Radiother. Oncol., 36 (1995) 203–210.

    Article  PubMed  CAS  Google Scholar 

  64. Wang CC. Reirradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results, Int. J. Radiat. Oncol. Biol. Phys., 13 (1987) 953–956.

    Article  PubMed  CAS  Google Scholar 

  65. Lee AWM, Law SCK, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: survival after local recurrence, Int. J. Radiat. Oncol. Biol. Phys., 26 (1993) 773–782.

    Article  PubMed  CAS  Google Scholar 

  66. Levendag PC, Meeuwis CA, and Visser AG. Reirradiation of recurrent head and neck cancers; external and/or interstitial radiation therapy, Radiother. Oncol., 23 (1992) 6–14.

    Article  PubMed  CAS  Google Scholar 

  67. Saroja KR, Hendrickson FR, Cohen L, et al. Reirradiation of locally recurrent tumors with fast neutrons, Int. J. Radiat. Oncol. Biol. Phys., 15 (1988) 115–121.

    Article  PubMed  CAS  Google Scholar 

  68. Housset M, Barrett JM, Brunel P, et al. Split-course interstitial brachytherapy with a source shift: the results of a new technique for salvage irradiation in recurrent inoperable cervical adenopathy 4 cm diameter in 23 patients, Int. J. Radiat. Oncol. Biol. Phys., 22 (1992) 1071–1074.

    Article  PubMed  CAS  Google Scholar 

  69. Langlois D, Hoffstetter S, Malissard L, et al. Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Centre Alexis Vautrin, Int. J. Radiat. Oncol. Biol. Phys., 14 (1988) 849–853.

    Article  PubMed  CAS  Google Scholar 

  70. McCollough KP and Blackwell CR. A dosimetric summary of common bolus materials, (Abstract) Med. Phys., 19 (1992) 835.

    Google Scholar 

  71. Chang F, Chang P, Benson K, et al. Study of Elasto-gel pads used as surface bolus material in high energy photon and electron therapy, Int. J. Radiat. Oncol. Biol. Phys., 22 (1991) 191–193.

    Article  Google Scholar 

  72. Nag S, Schuller D, Pak V, et al. IORT using electron beam or HDR brachytherapy for previously unirradiated head and neck cancers, Front. Radiat. Ther. Oncol., 31 (1997) 112–116.

    Article  PubMed  CAS  Google Scholar 

  73. Nag S, Schuller D, Pak V, Young D, Grecula J, Bauer C, et al. Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer, Radiother. Oncol., 41 (1996) 125–130.

    Article  PubMed  CAS  Google Scholar 

  74. Freeman S, Hamaker R, Singer M, et al. Intraoperative radiotherapy of skull base cancer, Laryngoscope, 101 (1991) 507–509.

    Article  PubMed  CAS  Google Scholar 

  75. Freeman SB, Hamaker RC, Rate WR, et al. Management of advanced cervical metastasis using intra-operative radiotherapy, Laryngoscope, 105 (1995) 575–578.

    Article  PubMed  CAS  Google Scholar 

  76. Garrett PG, Pugh NO, Ross HR, et al. Intraoperative radiation therapy for advanced recurrent head and neck cancer, Int. J. Radiat. Oncol. Biol. Phys., 13 (1987) 785–788.

    Article  PubMed  CAS  Google Scholar 

  77. Garrett PG, Hamaker R, Pugh N, et al. Intraoperative radiation therapy for advanced or recurrent head and neck malignancy. In: First International Symposium on Intraoperative Radiation Therapy, Dobelbower, RR and Abe, M, Boca Raton, FL, CRC (1989).

    Google Scholar 

  78. Garrett P, Rate W, Hamaker R, et al. Intraoperative radiation therapy for advanced or recurrent head and neck malignancies. In: Proceedings of the Third International Symposium on Intraoperative Radiation Therapy, Elmsford, NY, Pergamon (1991).

    Google Scholar 

  79. Garrett PG, Rate W, Hamaker R, et al. Surgical resection and intraoperative radiation therapy (IORT) for advanced or recurrent salivary gland malignancies. In: Fourth International Symposium on Intra-operative Radiation Therapy, 1992, pp. 199–202.

    Google Scholar 

  80. Rate W, Garrett P, Hamaker R, et al. Intraoperative radiation therapy for recurrent head and neck cancer, Cancer, 67 (1991) 2738–2740.

    Article  PubMed  CAS  Google Scholar 

  81. Rate W, Garrett P, Hamaker R, et al. Surgical resection and intraoperative radiation ( IORT) for advanced neck lymph node metastases. Fourth International Symposium on Intraoperative Radiation Therapy, 1992, pp. 203–206.

    Google Scholar 

  82. Foote RL, McCaffrey TV, Olsen KD, et al. Intraoperative electron beam radiation therapy for advanced or recurrent head and neck cancer., Fifth International IORT Symposium, Lyon, France, 1994.

    Google Scholar 

  83. Ling SM, Roach M, Fu KK, et al. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience, Cancer J. Sci. Am., 2 (1996) 321–329.

    PubMed  CAS  Google Scholar 

  84. Martinez-Monge R, Azinovic I, Alcalde J, et al. IORT in the management of locally advanced or recurrent head and neck cancer, Front. Radiat. Ther. Oncol., 31 (1997) 122–125.

    Article  PubMed  CAS  Google Scholar 

  85. Toita T, Nakano M, Takizawa Y, et al. Intraoperative radiation therapy (IORT) for head and neck cancer, Int. J. Radiat. Oncol. Biol. Phys., 30 (1994) 1219–1224.

    Article  PubMed  CAS  Google Scholar 

  86. Schmitt TH, Prades JM, Puel G, et al. IORT for locally advanced oropharyngeal carcinomas with major extension into the tongue base, Front. Radiat. Ther. Oncol., 31 (1997) 117–121.

    Article  PubMed  CAS  Google Scholar 

  87. Schuller DE, Grecula JC, Gahbauer RA, et al. Intensified regimen for advanced head and neck squamous cell carcinoma, Arch. Otolaryngol. Head Neck Surg., 123 (1997) 139–144.

    Article  PubMed  CAS  Google Scholar 

  88. Bachaud JM, Cohen-Jonathan E, Alzieu C, et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial, Int. J. Radiat. Oncol. Biol. Phys., 36 (1996) 999–1004.

    Article  PubMed  CAS  Google Scholar 

  89. Jacobs JR, Ahmad K, Casiano R, et al. Implications of positive surgical margins, Laryngoscope, 103 (1993) 64–68.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Foote, R.L. et al. (1999). IORT for Head and Neck Cancer. In: Gunderson, L.L., Willet, C.G., Harrison, L.B., Calvo, F.A. (eds) Intraoperative Irradiation. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-696-6_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-696-6_26

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5576-3

  • Online ISBN: 978-1-59259-696-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics